If you’re a high-functioning woman in your 40s who has been told her labs are “normal” but knows something has shifted — the energy, the recovery, the mirror, the gut, the hair — this is the episode that explains what’s actually happening. Dr. Tracy Page walks through the seven systems that decline in midlife, the peptide class quietly transforming functional medicine, and the FDA decision in April 2026 that just changed the regulatory landscape. Featuring the case of “Melissa,” a 48-year-old patient with a 10-year history of escalating symptoms hidden inside a high-functioning life.
In this episode, you will learn: why the standard reference range is failing midlife women; the actual statistics on muscle, bone, hormone, immune, and gut decline after 40; what peptides are and how they differ from hormones and pharmaceuticals; the FDA Category 2 reclassification of April 23, 2026, and what the July PCAC meeting will and will not decide; the seven peptide frontiers — from CJC-1295 and ipamorelin to BPC-157, thymosin alpha-1, larazotide, and tesamorelin; and the order-of-operations protocol used in clinical practice to sequence them safely.
Key Topics Covered:
Listen to discover how understanding the right signals can change everything.
Midlife Clarity with Dr. Tracy Page is a podcast for women over 40 navigating hormones, metabolism, strength, and healthy aging during midlife, perimenopause, and menopause.
Connect with Dr. Page:
Connect with The Wisconsin Institute of Functional Medicine (WIFM):
DISCLAIMER: The information shared on this podcast is for educational purposes only and is not intended as medical advice. It does not replace a consultation with your own physician or qualified health care provider. Always seek professional medical guidance regarding your personal health concerns.
© 2026 Dr. Tracy Page